1. Home
  2. BRC vs DYN Comparison

BRC vs DYN Comparison

Compare BRC & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brady Corporation

BRC

Brady Corporation

HOLD

Current Price

$90.73

Market Cap

3.7B

ML Signal

HOLD

DYN

Dyne Therapeutics Inc.

HOLD

Current Price

$18.37

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRC
DYN
Founded
1914
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.4B
IPO Year
1984
2020

Fundamental Metrics

Financial Performance
Metric
BRC
DYN
Price
$90.73
$18.37
Analyst Decision
Strong Buy
Analyst Count
0
17
Target Price
N/A
$39.94
AVG Volume (30 Days)
176.7K
2.1M
Earning Date
02-20-2026
02-26-2026
Dividend Yield
1.10%
N/A
EPS Growth
0.61
N/A
EPS
4.08
N/A
Revenue
$1,541,827,000.00
N/A
Revenue This Year
$6.90
N/A
Revenue Next Year
$3.83
N/A
P/E Ratio
$21.79
N/A
Revenue Growth
11.21
N/A
52 Week Low
$62.70
$6.36
52 Week High
$88.93
$25.00

Technical Indicators

Market Signals
Indicator
BRC
DYN
Relative Strength Index (RSI) 81.33 50.62
Support Level $83.52 $17.11
Resistance Level $86.37 $19.39
Average True Range (ATR) 1.53 0.95
MACD 0.47 0.20
Stochastic Oscillator 100.00 69.76

Price Performance

Historical Comparison
BRC
DYN

About BRC Brady Corporation

Brady Corp provides identification solutions and workplace safety products. The company offers identification and healthcare products that are sold under the Brady brand to maintenance, repair, and operations as well as original equipment manufacturing customers. Products include safety signs and labeling systems, material identification systems, wire identification, patient identification, and people identification. Brady also provides workplace safety and compliance products such as safety and compliance signs, asset tracking labels, and first-aid products. The company is organized and managed on a geographic basis with two reportable segments: Americas & Asia which derives maximum revenue, and Europe & Australia.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: